| Second Ebola Virus Treatment Approved | 05/11/2021 | |
| Another COVID-19 Vaccine Milestone Reached | 05/16/2021 | |
| Lawsuit Against HHS Highlights 340B Drug Pricing Dispute | 06/03/2021 | |
| FDA Issues EUA for Pfizer-BioNTech COVID-19 Vaccine | 02/16/2021 | |
| Assessing Approvals: FDA Updates on Dexmedetomidine Hydrochloride | 03/03/2021 | |
| Assessing the Asthma Management Guideline Updates | 04/16/2021 | |
| The FDA Expands Indication for Baloxavir Marboxil to Include Post-Exposure Influenza Prevention | 03/08/2021 | |
| Measles Vaccination Rates Drop—But Pharmacists Can Help | 03/06/2021 | |
| Exploring the Emergency Use Authorization for a Monoclonal Antibody Cocktail for COVID-19 | 03/07/2021 | |
| Monoclonal Antibody Treatment for COVID-19 Receives FDA Authorization | 02/08/2021 | |
| A Look into the Development of a COVID-19 Vaccine | 02/28/2021 | |
| CDC Playbook for COVID-19 Vaccine Distribution | 02/22/2021 | |
| FDA Approves Remdesivir, the First COVID-19 Treatment | 02/13/2021 | |
| Coagulopathy in COVID-19: Cause or Effect? | 09/11/2020 | |
| Novel Therapeutic & Prevention Approaches to the Novel Coronavirus | 09/07/2020 | |
| Drug Shortages During the COVID-19 Pandemic | 09/17/2020 | |
| HHS Approves Pharmacy COVID-19 Testing & Sets Testing Priorities | 09/16/2020 | |
| CDC Guidance for Pharmacy Staff on Minimizing Exposure to COVID-19 | 09/08/2020 | |
| Renin-Angiotensin-Aldosterone System Inhibitors in Patients with COVID-19 | 08/22/2020 | |
| FDA Issuance on Chloroquine & Hydroxychloroquine for COVID-19 | 08/31/2020 | |
| The DEA’s Adjustment to Schedule II Rules Amid COVID-19 | 09/18/2020 | |
| REMS-Required Drug Monitoring During the COVID-19 Pandemic | 08/24/2020 | |
| A Guide for Off-Label Use of Treatments for COVID-19 from the ASHP | 08/24/2020 | |
| Uncovering COVID-19 Treatments: An Update on the SOLIDARITY Trial | 08/24/2020 | |
| Update on Remdesivir, Investigational Antiviral for COVID-19 | 08/24/2020 | |
| Therapies & Vaccines on the Horizon for COVID-19 | 08/24/2020 | |
| Progress in Peanut Allergy: What to Know About the First FDA-Approved Treatment | 09/03/2020 | |
| A New Health Plan to Eliminate Diabetes Patients’ Out-of-Pocket Costs | 09/11/2020 | |
| FDA’s Pursuit in Progressing Gene Therapy While Maintaining Safety | 09/07/2020 | |
| FDA’s Fight Against the Novel Coronavirus | 08/31/2020 | |
| The Alarming Rate of Overlapping Benzodiazepine & Opioid Prescriptions | 09/05/2020 | |
| Survey Says: Key Findings on Drug Information Centers | 09/07/2020 | |
| Top 10 Med Errors & Hazards, Part 2 | 09/03/2020 | |
| Top 10 Med Errors & Hazards, Part 1 | 09/09/2020 | |
| DEA’s Proposals for Opioid Regulations | 09/02/2020 | |
| Reports on Investigational Agents to Counter Antimicrobial Resistance | 09/03/2020 | |
| A Look at Diabetes Drugs That Reduce the Risk of Cardiovascular Disease | 04/27/2025 | |
| Type 1 Diabetes Research | 11/07/2018 | |
| Antimicrobial Drug Resistance | 12/03/2018 | |
